Literature DB >> 19657603

[Prostatic carcinoma screening: sense ur nonsense?].

Stephan Madersbacher1, Christian Vutuc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19657603     DOI： 10.1007/s00508-009-1199-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  10 in total

1.  Screening for prostate cancer--the controversy that refuses to die.

Authors:  Michael J Barry
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

Review 2.  Watchful waiting and active surveillance: the current position.

Authors:  Jan Adolfsson
Journal:  BJU Int       Date:  2008-04-14       Impact factor: 5.588

3.  Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality.

Authors:  C Vutuc; T Waldhoer; S Madersbacher; M Micksche; G Haidinger
Journal:  Eur J Cancer Prev       Date:  2001-10       Impact factor: 2.497

4.  Prostate cancer and prostate-specific antigen (PSA) screening in Austria.

Authors:  Christian Vutuc; Eva S Schernhammer; Gerald Haidinger; Thomas Waldhör
Journal:  Wien Klin Wochenschr       Date:  2005-07       Impact factor: 1.704

5.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

6.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

7.  PSA testing in Austria: induced morbidity and saved mortality.

Authors:  Christian Vutuc; Thomas Waldhoer; Gerhard Lunglmayr; Wolfgang Hoeltl; Gerald Haidinger
Journal:  Eur J Cancer Prev       Date:  2009-09       Impact factor: 2.497

8.  Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

Authors:  Simon M Collin; Richard M Martin; Chris Metcalfe; David Gunnell; Peter C Albertsen; David Neal; Freddie Hamdy; Peter Stephens; J Athene Lane; Rollo Moore; Jenny Donovan
Journal:  Lancet Oncol       Date:  2008-04-16       Impact factor: 41.316

9.  [Permanent interstitial brachytherapy (seeds) for patients with primary localized prostate cancer: analysis of 100 patients].

Authors:  Gregor Goldner; Nevin Ozdemiroglu; Stefan Wachter; Thomas Hendrik Knocke; Richard Pötter
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

10.  Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality.

Authors:  Georg Bartsch; Wolfgang Horninger; Helmut Klocker; Alexandre Pelzer; Jasmin Bektic; Wilhelm Oberaigner; Harald Schennach; Georg Schäfer; Ferdinand Frauscher; Mathieu Boniol; Gianluca Severi; Chris Robertson; Peter Boyle
Journal:  BJU Int       Date:  2008-04       Impact factor: 5.588
  10 in total
  1 in total

1.  [Austrian patient information materials on PSA-screening do not meet international evidence-based standards].

Authors:  Michaela Strobelberger; Angela Kaminski; Gerald Gartlehner
Journal:  Wien Med Wochenschr       Date:  2011-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.